Eprex

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Recent publications have suggested renoprotective actions for erythropoietin in certain models of acute kidney injury. In a study… (More)
Is this relevant?
2012
2012
BACKGROUND Investigations have attempted to modify the outcome of tubular injury by either ameliorating renal tubular damage or… (More)
  • table 1
  • figure 1
Is this relevant?
Review
2008
Review
2008
BACKGROUND Since 1988, millions of patients have received epoetin products intravenously (IV) and subcutaneously. In 1998… (More)
Is this relevant?
2006
2006
4. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 1999; 34… (More)
  • figure 1
  • table 1
Is this relevant?
2006
2006
This study focuses on the development and application of biophysical methodology to characterize conformations of Epogen and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND The incidence of pure red cell aplasia (PRCA) in chronic kidney disease patients treated with epoetins increased… (More)
Is this relevant?
Review
2005
Review
2005
Several diseases and disorders are treatable with therapeutic proteins, but some of these products may induce an immune response… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone… (More)
Is this relevant?
2004
2004
BACKGROUND Recombinant human erythropoietin is the standard treatment for anaemia related to chronic kidney disease, and its… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Sabine Louët responds: In researching the news story, I had several interviews with Huub Schellekens, who explained to me the key… (More)
  • figure 1
Is this relevant?